GGrantIndex
← Leaderboards

Apath, Llc

Saint Louis, MO

Compare ↔
$9,279,572
Total funding
17
Grants

Funding over time

peak $2.9M · FY200508
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08

Funding mix

By agency

NIH$9,279,572 · 17

By mechanism

R44$3,684,488 · 5
R43$1,669,529 · 8
U01$1,437,767 · 1
R01$1,350,000 · 1
R41$741,038 · 1
R21$396,750 · 1

Investigators at Apath, Llc

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Therapeutics for Ebola virus$1,350,000
R01 · FY2005 · AI
Developing small molecule therapeutics for West Nile virus$725,606
U01 · FY2007 · AI
Developing small molecule therapeutics for West Nile virus$712,161
U01 · FY2008 · AI
Replicon-based screening for inhibitors of alphaviruses$483,532
R43 · FY2004 · AI
Replicon-based screening for inhibitors of alphaviruses$475,049
R43 · FY2005 · AI
Antiviral Screening Assays Based on HCV Replicons$429,325
R44 · FY2002 · AI
Molecular tools for Bunyavirus antiviral screening$413,699
R41 · FY2005 · AI
Screening for anti-RSV compounds with indicator cells$411,213
R44 · FY2003 · AI
Hepatitis C Virus RNA Quantitation Using The 3'NTR$378,638
R44 · FY2001 · AI
Hepatitis C Virus RNA Quantitation Using The 3'NTR$371,356
R44 · FY2002 · AI
Indicator cells for antiviral screening for filoviruses$368,309
R44 · FY2005 · AI
Screening for anti-RSV compounds with indicator cells$359,466
R44 · FY2004 · AI
Indicator cells for antiviral screening for filoviruses$357,582
R44 · FY2004 · AI
Molecular tools for Bunyavirus antiviral screening$327,339
R41 · FY2004 · AI
Antiviral Screening Assays Based on HCV Replicons$320,675
R44 · FY2003 · AI
Transgenic indicator cells for influenza virus$308,949
R44 · FY2005 · AI
Transgenic indicator cells for influenza virus$272,949
R44 · FY2006 · AI
Screening for antivirals against flaviviruses$209,250
R21 · FY2003 · AI
Screening for antivirals against flaviviruses$187,500
R21 · FY2002 · AI
Multiplexed Gene Assays by Microtiter Plate Microarrays$111,600
R43 · FY2003 · AI